MG
TNYA icon

Marex Group’s Tenaya Therapeutics TNYA Stock Holding History

Marex Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Buy
235,500
+50,489
+27% +$37.3K ﹤0.01% 920
2025
Q4 		$132K Sell
185,011
-117,489
-39% -$160K ﹤0.01% 886
2025
Q3 		$490K Sell
302,500
-110,000
-27% -$111K ﹤0.01% 503
2025
Q2 		$252K Hold
412,500
– – ﹤0.01% 483
2025
Q1 		$235K Buy
412,500
+150,000
+57% +$148K ﹤0.01% 538
2024
Q4 		$375K Buy
+262,500
New +$588K 0.01% 411

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group's TNYA Position: Q1 2026 in Review

Marex Group increased its Tenaya Therapeutics (TNYA) stake by 27% in Q1 2026, buying an estimated $37.3K and bringing the position to 235,500 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #920.

Marex Group first reported a position in TNYA in Q4 2024 and has held it in 6 quarters since. The position peaked at $490K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Marex Group held 235,500 shares of Tenaya Therapeutics worth $163K as of Q1 2026.
  • Marex Group bought 50,489 Tenaya Therapeutics shares in Q1 2026, an estimated $37.3K.
  • Tenaya Therapeutics made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #920 holding.
  • Marex Group first reported a position in Tenaya Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Marex Group's Tenaya Therapeutics position peaked at $490K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.